{"altmetric_id":3307817,"counts":{"readers":{"mendeley":24,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["Cancer411Today"],"posts_count":1}},"selected_quotes":["\u25c8 Adaptive Mitochondrial Reprogramming and Resistance to PI3K Therapy: Background:Small molecule inhibitor... \u25c8"],"citation":{"abstract":"Small molecule inhibitors of phosphatidylinositol-3 kinase (PI3K) have been developed as molecular therapy for cancer, but their efficacy in the clinic is modest, hampered by resistance mechanisms.","abstract_source":"pubmed","altmetric_jid":"4f6fa4ee3cf058f610002c44","authors":["Jagadish C. Ghosh","Markus D. Siegelin","Valentina Vaira","Alice Faversani","Michele Tavecchio","Young Chan Chae","Sofia Lisanti","Paolo Rampini","Massimo Giroda","M. Cecilia Caino","Jae Ho Seo","Andrew V. Kossenkov","Ryan D. Michalek","David C. Schultz","Silvano Bosari","Lucia R. Languino","Dario C. Altieri","Ghosh JC","Siegelin MD","Vaira V","Faversani A","Tavecchio M","Chae YC","Lisanti S","Rampini P","Giroda M","Caino MC","Seo JH","Kossenkov AV","Michalek RD","Schultz DC","Bosari S","Languino LR","Altieri DC"],"doi":"10.1093\/jnci\/dju502","endpage":"dju502","first_seen_on":"2015-02-04T09:43:50+00:00","funders":["niehs","nci"],"issns":["1460-2105","0027-8874"],"issue":"3","journal":"JNCI: Journal of the National Cancer Institute","last_mentioned_on":1423027967,"links":["http:\/\/jnci.oxfordjournals.org\/content\/107\/3\/dju502.short?rss=1"],"pdf_url":"http:\/\/jnci.oxfordjournals.org\/content\/107\/3\/dju502.full.pdf","pmid":"25650317","pubdate":"2015-03-15T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"dju502","subjects":["neoplasms"],"title":"Adaptive Mitochondrial Reprogramming and Resistance to PI3K Therapy","type":"article","volume":"107","mendeley_url":"http:\/\/www.mendeley.com\/research\/adaptive-mitochondrial-reprogramming-resistance-pi3k-therapy"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":4715210,"mean":5.6976580270372,"rank":3344106,"this_scored_higher_than_pct":16,"this_scored_higher_than":765910,"rank_type":"exact","sample_size":4715210,"percentile":16},"similar_age_3m":{"total_number_of_other_articles":164526,"mean":8.770387077952,"rank":114759,"this_scored_higher_than_pct":19,"this_scored_higher_than":32087,"rank_type":"exact","sample_size":164526,"percentile":19},"this_journal":{"total_number_of_other_articles":3053,"mean":9.7674187418087,"rank":2428,"this_scored_higher_than_pct":13,"this_scored_higher_than":414,"rank_type":"exact","sample_size":3053,"percentile":13},"similar_age_this_journal_3m":{"total_number_of_other_articles":65,"mean":16.31959375,"rank":56,"this_scored_higher_than_pct":12,"this_scored_higher_than":8,"rank_type":"exact","sample_size":65,"percentile":12}}},"demographics":{"poster_types":{"practitioner":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1}},"mendeley":{"by_status":{"Unspecified":2,"Researcher":6,"Student  > Ph. D. Student":5,"Student  > Postgraduate":1,"Student  > Master":4,"Other":3,"Student  > Bachelor":3},"by_discipline":{"Medicine and Dentistry":5,"Chemistry":1,"Sports and Recreations":1,"Psychology":1,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":6,"Biochemistry, Genetics and Molecular Biology":7,"Unspecified":2}}},"geo":{"mendeley":{"GB":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/Cancer411Today\/status\/562846204833579008","license":"datasift","citation_ids":[3307817],"posted_on":"2015-02-04T05:32:47+00:00","author":{"name":"\u25c8 Cory B. Phillips \u25c8","url":"http:\/\/www.linkedin.com\/in\/corybphillips","image":"https:\/\/pbs.twimg.com\/profile_images\/1699132217\/rad1_normal.PNG","description":"The latest news on Cancer Diagnosis, Treatments, Recovery, and Research.  Follow @Imaging411Today for Diagnostic Medical Imaging, PACS\/RIS, & Radiation Safety.","id_on_source":"Cancer411Today","tweeter_id":"439596634","geo":{"lt":null,"ln":null},"followers":233},"tweet_id":"562846204833579008"}]}}